Patient outcome: satisfaction with care: average score (ZUF8, high = better satisfaction) · patients with schizophrenia or related psychoses
1 finding from 1 review
Drug attitude—DAI · patients with schizophrenia or related psychoses
1 finding from 1 review
Patient outcome: Quality of life · patients with schizophrenia or related psychoses
1 finding from 1 review
Retention in treatment · people with substance use (adults, young adults, adolescents)
1 finding from 1 review
PTSD symptoms, post‐treatment (self‐reported or clinician‐rated) · survivors of sexual violence and abuse
1 finding from 1 review
Depressive symptoms · survivors of sexual violence and abuse
1 finding from 1 review
Dropout from treatment (a count of participants not meeting study‐defined completion threshold) · survivors of sexual violence and abuse
Summary of findings table ‐ Psychosocial interventions showed no clear difference in dropout from treatment (a count of participants not meeting… compared with inactive control (low certainty).
1 finding from 1 review
Anxiety (adverse effect, post‐intervention) · adults (aged 16 years and over) with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐related adverse events Depression · adults (aged 16 years and over) with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with placebo or active control (very low certainty).
1 finding from 1 review
Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with acute or chronic CME following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with active control (very low certainty).
1 finding from 1 review
Persistence of visual improvement one month after discontinuation of treatment · participants with acute or chronic CME following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Persistence of visual improvement one month after discontinuation of treatment · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment withdrawal · people with drug‐resistant focal epilepsy
Pregabalin showed no clear difference in treatment withdrawal for any reason compared with active comparators (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with drug‐resistant focal epilepsy
1 finding from 1 review
Motivation for treatment/change · people with substance use disorders
1 finding from 1 review
Retention in treatment · people with substance use disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for extra treatment · adults and children with CF
1 finding from 1 review
Active range of motion (shoulder abduction) without pain. Scale: 0 to 180 degrees№ of participants: 143(3 RCTs) · rotator cuff disease
1 finding from 1 review
Adherence · Participants of any age with either unilateral strabismic, anisometropic, or mixed (strabismic‐refractive) amblyopia; deprivation…
1 finding from 1 review